Cargando…
Racial disparities in patients diagnosed with light chain (AL) amyloidosis
Autores principales: | D’Souza, Anita, Pezzin, Liliana, Laud, Purushottam, Singh, Ashima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036230/ https://www.ncbi.nlm.nih.gov/pubmed/33839739 http://dx.doi.org/10.1038/s41408-021-00466-8 |
Ejemplares similares
-
Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis
por: Chakraborty, Rajshekhar, et al.
Publicado: (2023) -
Outcomes of t(11;14) light chain (AL) amyloidosis after autologous stem cell transplantation: benchmark for new therapies
por: Bal, Susan, et al.
Publicado: (2023) -
Localized Lymph Node Light Chain Amyloidosis
por: Dhakal, Binod, et al.
Publicado: (2015) -
Recent advances in understanding and treating immunoglobulin light chain amyloidosis
por: Badar, Talha, et al.
Publicado: (2018) -
Socioeconomic Disparities in Mortality Among Women With Incident Breast Cancer Before and After Implementation of Medicare Part D
por: Nattinger, Ann B., et al.
Publicado: (2017)